CurvaFix
CurvaFix develops implantable devices for surgical repair of fractures in curved bones, with a focus on pelvic fragility and high-impact pelvic fractures. Its intramedullary implants are designed to follow the natural shape of the pelvis, aiming to improve surgical outcomes and restore mobility for patients.
Facts
- HQ
- Bellevue, WA, United States
- Sectors
- Medical Equipment Manufacturing
- Founded
- 2013
- Employees
- 39
- Stage
- Series C
- Members see funding amounts. .
Is this your organization? Claim it
CurvaFix to Host OTA Industry Session, Present Multicenter Poster Showing Safe, Effective CurvaFix IM Implant for Pelvic Fractures
CurvaFix will host an industry session at the Orthopaedic Trauma Association annual meeting to demonstrate its CurvaFix IM Implant for treating complex pelvic fractures and will present a multicenter poster showing the implant is safe and effective. The company will also showcase procedures at its booth and feature panel discussions with multiple orthopedic surgeons and researchers.
CurvaFix debuts CurvaFix® IM Implants for geriatric pelvic fragility fractures at ACEP, promoting surgical alternative to conservative care
CurvaFix is showcasing its CurvaFix® IM Implants—curved intramedullary devices designed for geriatric fragility fractures of the pelvis—at the ACEP Scientific Assembly to promote a surgical option that may improve mobility and outcomes for patients often treated non-surgically. The company says the implants provide robust, stable fixation even in weakened bone and are gaining adoption among orthopedic trauma surgeons across the U.S.
CurvaFix Raises $39M Series C Led by MVM Partners; Mark Foster Named CEO as Founder Moves to Advisor
CurvaFix raised $39 million in a Series C round led by MVM Partners to fund a nationwide launch of its CurvaFix IM Implant for Fragility Fractures of the Pelvis, and named Mark Foster as CEO while founder Steve Dimmer moves to a strategic advisory role.
CurvaFix launches 7.5mm curved CurvaFix® IM implant, over two dozen implants already used
CurvaFix introduced a smaller-diameter 7.5mm CurvaFix® intramedullary implant to simplify surgery and provide stable fixation for small-boned or osteoporotic patients, with over two dozen already implanted; the company will showcase it alongside its 9.5mm device at AAOS 2023. A surgeon reported positive outcomes using the 7.5mm implant for pelvic fixation in challenging cases including sacral and rami nonunions.
CurvaFix Announces FDA 510(k) Clearance for 7.5mm Intramedullary Implant for Pelvic Fractures
CurvaFix won FDA 510(k) clearance for a smaller 7.5mm-diameter CurvaFix Intramedullary Implant for pelvic fracture fixation, intended to provide curved, stable fixation in smaller patients and potentially reduce pain and hasten recovery. The company now offers implants in 7.5mm and 9.5mm diameters with lengths from 90mm to 180mm to address narrow, curved pelvic corridors and geriatric fragility fractures.
CurvaFix announces FDA 510(k) clearance for 7.5mm CurvaFix IM implant to treat pelvic fractures
CurvaFix received FDA 510(k) clearance for a smaller 7.5mm-diameter CurvaFix IM implant for pelvic fracture fixation, expanding its implant options to better serve smaller and geriatric patients with a minimally invasive, curved fixation device.
CurvaFix Adds Three Surgeon Advisory Board Members to Advance CurvaFix IM Implant for Pelvic Fractures
CurvaFix added three surgeon advisors with expertise in orthopedic trauma, pelvis/acetabular reconstruction, and fragility fractures to support development and commercialization of its CurvaFix IM Implant as a minimally invasive pelvic fracture treatment.
CurvaFix to Present CurvaFix IM Implant for Fragility and High-Impact Pelvic Fractures at OTA 38th Annual Meeting
CurvaFix will present an educational session and exhibit at the Orthopaedic Trauma Association annual meeting to highlight its minimally invasive CurvaFix IM Implant for fragility and high-impact pelvic fractures and share recent U.S. case updates.
CurvaFix Hits 100th Surgery Using CurvaFix IM Implant to Fix Pelvic Fragility Fracture at University of Missouri
CurvaFix reports completing its 100th surgical use of the CurvaFix IM Implant to repair a pelvic fragility fracture at University Hospital, University of Missouri, where a 70-year-old patient with osteoporosis received minimally invasive curved fixation that navigated existing hardware and provided stable fixation in poor-quality bone.
CurvaFix announces FDA-cleared curved pelvic implant and begins commercialization to improve fracture fixation
CurvaFix has received FDA clearance and started commercializing the only pelvic fracture implant designed to follow the pelvis’s natural curvature, addressing limitations of traditional straight screws and plates. The company positions its curved implant as a solution for challenging pelvic anatomy that can cause failures with standard devices.
CurvaFix Reports FDA Clearances, Clinical Milestones, and $39M Series C as It Expands Curved Intramedullary Pelvic Implant Adoption
CurvaFix is a company developing the only intramedullary pelvic trauma implant that follows the pelvis curve; recent milestones include FDA clearances, product launches (including a smaller-diameter implant), clinical use milestones, presentations at major orthopedic meetings, and funding rounds including a $39M Series C.
CurvaFix Secures $10.75M Series B Led by Sectoral Asset Management; New Board Appointments Announced
CurvaFix raised $10.75 million in an oversubscribed Series B led by Sectoral Asset Management, which also joined the company's board; funds will complete the RESTORE clinical study and start commercialization of its CurvaFix Intramedullary Rodscrew for pelvic fractures.
People
-
Jeffrey Poole Executive, Executive Officer, Chief Financial Officer
-
Mark Foster Executive, Executive Officer, Director, President and CEO